Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 31 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Miró O, Rosselló X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero-Puente P, Jacob J, Bueno H, Pocock SJ, on behalf of the ICA-SEMES Research Group. Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Ann Intern Med 2017;167:698-705. [Ref.ID 102155]
2. Cita con resumen
Giustino G, Baber U, Sartori S, Mehran M, Mastoris I, Kini AS, Sharma SK, Pocock SJ, Dangas GD. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.. Journal of The Americal College of Cardiology 2015;65:1298-310. [Ref.ID 99446]
3. Cita con resumen
Julian DG, Pocock SJ. Effects of long-term use of cardiovascular drugs. Lancet 2015;385:325. [Ref.ID 98770]
4.Tiene citas relacionadas Cita con resumen
Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594-604. [Ref.ID 94276]
5.Tiene citas relacionadas Cita con resumen
Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J, for the Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307:1151-60. [Ref.ID 92533]
6.Tiene citas relacionadas
Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R, on behalf of the HORIZONS-AMI Trial Investigators. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 2011;377:2193-204. [Ref.ID 91347]
7.
White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011;342:910-2. [Ref.ID 90484]
8.Tiene citas relacionadas Cita con resumen
Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, for the EMPHASIS-HF Study group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21. [Ref.ID 90013]
9.Tiene citas relacionadas Cita con resumen
Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan B-A, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, for the FAIR-HF Trial Investigators. Ferric carboxymatose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-48. [Ref.ID 87281]
10.Tiene citas relacionadas Cita con resumen
Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikoslky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW, for the HORIZONS-AMI Trial Investigators. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009;374:1149-59. [Ref.ID 86874]
11.Tiene citas relacionadas Cita con resumen
Pocock SJ, Smeeth L. Insulin glargine and malignancy: an unwarranted alarm. Lancet 2009;374:511-3. [Ref.ID 86414]
12.Tiene citas relacionadas Cita con resumen
Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJV, for the RECORD Study Team. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009;373:2125-35. [Ref.ID 86100]
13. Cita con resumen
Pocock SJ, Ware JH. Translating statistical findings into plain English. Lancet 2009;373:1926-8. [Ref.ID 85993]
14.Tiene citas relacionadas
Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R, for the HORIZONS-AMI Trial Investigators. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009;360:1946-59. [Ref.ID 85773]
15.Tiene citas relacionadas
Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373:1190-7. [Ref.ID 85565]
16.Tiene citas relacionadas Cita con resumen
Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, for the HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30. [Ref.ID 82954]
17.Tiene citas relacionadas Cita con resumen
Pocock SJ, Lubsen J. More on subgroup analyses in clinical trials. N Engl J Med 2008;358:2076. [Ref.ID 82852]
18.Tiene citas relacionadas Cita con resumen
Pocock SJ. Safety of drug-eluting stents: demystifying network meta-analysis. Lancet 2007;370:2099-100. [Ref.ID 81849]
19.
Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ, for the ACUITY Investigators. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management. One-year results from the ACUITY trial. JAMA 2007;298:2497-506. [Ref.ID 81745]
20. Cita con resumen
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, for the STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7. [Ref.ID 81351]
Seleccionar todas
 
 1 a 20 de 31 siguiente >>